Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950130-97-001485
Filing Date
1997-04-02
Accepted
1997-04-02 00:00:00
Documents
15
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 219215
2 CERTIFICATE OF AMENDMENT, DATED AUGUST 26, 1996 EX-3.1.2 36311
3 CERTIFICATE OF AMENDMENT, DATED NOVEMBER 25, 1996 EX-3.1.4 3525
4 EMPLOYMENT AGREEMENT - JOHN SPITZNAGEL EX-10.20.1 12823
5 EMPLOYMENT AGREEMENT - PETER M. ROGALIN EX-10.20.2 12914
6 LICENSE AGREEMENT EX-10.81 147675
7 LICENSE AGREEMENT EX-10.82 75302
8 AGREEMENT FOR OAKVILLE MANUFACTURING FACILITY EX-10.83 26631
9 DIVESTITURE AGREEMENT EX-10.84 110180
10 STOCK PURCHASE AGREEMENT EX-10.85 121379
11 STATEMENT RE COMPUTATION OF EARNINGS EX-11 2879
12 SUBSIDIARIES OF THE REGISTRANT EX-21 910
13 CONSENT OF COOPERS & LYBRAND L.L.P. EX-23 1066
14 FINANCIAL DATA SCHEDULES EX-27 2637
15 LIST OF PRIVATE PLACEMENT INVESTORS EX-99.1 2369
  Complete submission text file 0000950130-97-001485.txt   778868
Mailing Address MERIDIAN CTR II 4 INDUSTRIAL WAY WEST EATONTOWN NJ 07724
Business Address MERIDIAN CENTRE II 4 INDUSTRIAL WAY W EATONTOWN NJ 07724 9083891182
ROBERTS PHARMACEUTICAL CORP (Filer) CIK: 0000853022 (see all company filings)

EIN.: 222429994 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19173 | Film No.: 97573371
SIC: 2834 Pharmaceutical Preparations